| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1101557100 |
| P356 | DOI | 10.1007/S11926-018-0726-4 |
| P932 | PMC publication ID | 5857275 |
| P698 | PubMed publication ID | 29550929 |
| P2093 | author name string | Ingrid E Lundberg | |
| Valérie Leclair | |||
| P2860 | cites work | Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C- | Q27021322 |
| A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis | Q33569443 | ||
| Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients | Q33649923 | ||
| Polymyositis and dermatomyositis (second of two parts) | Q33909233 | ||
| Polymyositis and dermatomyositis (first of two parts) | Q33911013 | ||
| Evaluation and construction of diagnostic criteria for inclusion body myositis | Q34043780 | ||
| Inclusion body myositis and myopathies | Q34289237 | ||
| A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy | Q34520109 | ||
| Polymyositis: an overdiagnosed entity | Q34536136 | ||
| Polymyositis and dermatomyositis | Q34542218 | ||
| Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies. | Q52943790 | ||
| Editorial: A New Classification of Adult Autoimmune Myositis. | Q53375302 | ||
| Development of classification and response criteria for rheumatic diseases | Q57244852 | ||
| 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands | Q57752724 | ||
| A novel autoantibody to a 155-kd protein is associated with dermatomyositis | Q58490778 | ||
| Inclusion body myositis | Q70536272 | ||
| Inflammatory myopathies | Q71581588 | ||
| Classification criteria for polymyositis and dermatomyositis | Q72335478 | ||
| Unicorns, dragons, polymyositis, and other mythological beasts | Q73797234 | ||
| Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? | Q77802015 | ||
| Classification criteria for psoriatic arthritis: development of new criteria from a large international study | Q80001900 | ||
| Classification criteria for rheumatic diseases: why and how? | Q81377286 | ||
| Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy | Q88013139 | ||
| Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria | Q95365536 | ||
| Expression of immunoreactive major histocompatibility complex products in human skeletal muscles | Q34686933 | ||
| International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. | Q35179618 | ||
| Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features | Q36150826 | ||
| Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients | Q36190260 | ||
| Polymyositis, dermatomyositis and inclusion-body myositis | Q36439792 | ||
| Classification criteria in rheumatic diseases: a review of methodologic properties | Q36956490 | ||
| Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study | Q37604939 | ||
| Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review | Q37674765 | ||
| Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis | Q37726608 | ||
| Acquired immune and inflammatory myopathies: pathologic classification | Q37936148 | ||
| The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome | Q38202468 | ||
| Distinctions between diagnostic and classification criteria? | Q38380153 | ||
| A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. | Q38596370 | ||
| The Clinical Features of Myositis-Associated Autoantibodies: a Review | Q38603422 | ||
| Myositis-specific autoantibodies: an important tool to support diagnosis of myositis | Q38646384 | ||
| Diagnostic criteria for inclusion body myositis | Q38793315 | ||
| Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study | Q38834515 | ||
| 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatri | Q38849144 | ||
| Recent advances in dermatomyositis-specific autoantibodies | Q38929856 | ||
| Advances in serological diagnostics of inflammatory myopathies | Q38930955 | ||
| The role of magnetic resonance imaging techniques in evaluation and management of the idiopathic inflammatory myopathies. | Q39088767 | ||
| State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis | Q39408875 | ||
| Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group. | Q39800399 | ||
| Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera | Q39975993 | ||
| Inclusion body myositis: A distinct variety of idiopathic inflammatory myopathy | Q40119689 | ||
| A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups | Q40743626 | ||
| Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis | Q40783082 | ||
| Classification criteria for the idiopathic inflammatory myopathies | Q41647350 | ||
| Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies | Q45112924 | ||
| 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. | Q47699498 | ||
| 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology | Q47924181 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | globulins | Q321710 |
| blood proteins | Q425056 | ||
| myositis | Q1433212 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 18 | |
| P577 | publication date | 2018-03-17 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter. | |
| P478 | volume | 20 |
| Q96137016 | Assessment of Optimal Screening Tests for the Detection of an Inflammatory Myositis-associated Interstitial Lung Disease |
| Q92801301 | Increased Serum Matrix Metalloproteinase-9 Levels are Associated with Anti-Jo1 but not Anti-MDA5 in Myositis Patients |
| Q99630519 | Paraneoplastic dermatomyositis associated with metastatic leiomyosarcoma of unknown primary |
| Q98292008 | Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies |
| Q93164366 | The clinical phenotype associated with antisynthetase autoantibodies |
Search more.